Here Come More Gene Therapies — And More Pricing Debates – Forbes
Forbes |
Here Come More Gene Therapies — And More Pricing Debates
Forbes The Food and Drug Administration approved the first gene therapy in August and is considering another for approval soon. Designed as one-time treatments, they don't come cheap, and that's raising concerns among health care payers. (AP Photo/Andrew … Gene Therapy for Blindness Appears Initially Effective, Says US FDA The FDA is Considering a Landmark Approval of Gene Therapy to … With AdComm meeting looming, FDA shares concerns about Spark's lead gene therapy |
